Last updated on January 2020

REMOGEN Omega Versus Cationorm in the Treatment of Patients Suffering From Dry Eye


Brief description of study

The efficacy and safety of Remogen Omega in the treatment of dry eye signs and symptoms will be investigated in comparison to Cationorm.

Clinical Study Identifier: NCT03460548

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.